Chemoimmunotherapy after progression on single-agent pembrolizumab for metastatic urothelial carcinoma: A case series

Daniel S. Childs, J. Fernando Quevedo, Brian A. Costello, Lance C. Pagliaro

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Chemoimmunotherapy after progression on single-agent pembrolizumab for metastatic urothelial carcinoma: A case series'. Together they form a unique fingerprint.

Medicine & Life Sciences